Neurogastrx
OverviewSuggest Edit
Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment. Its lead product is under development for the treatment of gastroparesis, a debilitating condition caused by abnormal gastric function.
| Type | Private | |
| Founded | 2012 | |
| HQ | Woburn, US | Map |
| Website | neurogastrx.com |
Locations
Latest Updates
| Employees (est.) (Dec 2019) | 9 |
Key People/Management at Neurogastrx
Klaus Veitinger
Jim O'Mara
David Allison
Kevin Koch
Aaron Royston
Neurogastrx Office Locations
Neurogastrx Financials and Metrics
Summary Metrics
Founding Date | 2012 |
Neurogastrx total Funding | $45 m |
Neurogastrx latest funding size | $45 m |
Time since last funding | 2 years ago |
Neurogastrx investors | 5AM Ventures, OrbiMed, venBio Partners |
Neurogastrx Online and Social Media Presence
Neurogastrx's Trends
Neurogastrx Frequently Asked Questions
When was Neurogastrx founded?
Neurogastrx was founded in 2012.
Who are Neurogastrx key executives?
Neurogastrx's key executives are Klaus Veitinger, Jim O'Mara and David Allison.
How many employees does Neurogastrx have?
Neurogastrx has 9 employees.
Who are Neurogastrx competitors?
Competitors of Neurogastrx include Bellerophon Therapeutics, Innovation Pharmaceuticals and CorMedix.
Where is Neurogastrx headquarters?
Neurogastrx headquarters is located at 600 Unicorn Park Dr, Woburn.
Where are Neurogastrx offices?
Neurogastrx has an office in Woburn.
How many offices does Neurogastrx have?
Neurogastrx has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies